ARCHIVES

Momentum Continues For Private Development Of Free Standing Cancer Centers

This article is from The Cancer Letter archive.

Vol. 11 No. 29 | July 19, 1985

Download PDF Visit The Full Archive

Related Articles

Prevention Trial Could Stand On Its Own

October 28, 1994

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

NCI Starts “Exceptional Responders” Study

September 26, 2014

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001